amobarbital has been researched along with Parkinsonian Disorders in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ALEMA, G | 1 |
| ROSADINI, G | 1 |
| ROSSI, GF | 1 |
| GILMAN, S | 1 |
| MACFADYEN, DJ | 1 |
| DENNY-BROWN, D | 1 |
2 other studies available for amobarbital and Parkinsonian Disorders
| Article | Year |
|---|---|
[Preliminary experiments on the effects of the intracarotid introduction of sodium amytal in parkinsonian syndromes].
Topics: Amobarbital; Parkinson Disease; Parkinsonian Disorders | 1961 |
DECEREBRATE PHENOMENA AFTER CAROTID AMOBARBITAL INJECTION.
Topics: Alcoholism; Amobarbital; Angiography; Athetosis; Carotid Arteries; Chorea; Decerebrate State; Hemipl | 1963 |